CJC-1295 (NO DAC) + Ipamorelin Dosage, Protocol, and Reconstitution Guide

CJC-1295 (NO DAC) + Ipamorelin

This combination pairs a growth hormone releasing hormone peptide with a growth hormone secretagogue to create a stronger natural GH pulse. It is one of the most commonly discussed GH support combinations for recovery, body composition, sleep, and lean mass support.

How It Works

GHRH Signal (CJC-1295) + Ghrelin Signal (Ipamorelin) → GH Pulse ↑↑ → IGF-1 ↑ → Recovery + Fat Loss + Lean Mass Support

CJC-1295 (NO DAC) stimulates the pituitary through GHRH pathways, while Ipamorelin activates the ghrelin receptor. Together, they create a stronger pulsatile growth hormone response than either peptide alone.

Protocol

Blended Vial Protocol

Blend: 5 mg CJC-1295 + 5 mg Ipamorelin

Add 3.0 mL bacteriostatic water

Each peptide concentration = 1.67 mg/mL

1 unit = 16.7 mcg CJC-1295 + 16.7 mcg Ipamorelin

1 unit = about 33 mcg total combined

Weeks 1–2

Dose100 mcg of each peptide

Combined Total200 mcg total

Units6 units

Weeks 3–4

Dose150 mcg of each peptide

Combined Total300 mcg total

Units9 units

Weeks 5–8

Dose200 mcg of each peptide

Combined Total400 mcg total

Units12 units

Weeks 9–12

Dose250 mcg of each peptide

Combined Total500 mcg total

Units15 units

Separate Vials Protocol

Use 1 vial of CJC-1295 (5 mg) and 1 vial of Ipamorelin (5 mg)

Add 3.0 mL bacteriostatic water to each vial

1 unit from each vial = 16.7 mcg

Weeks 1–2

CJC-12956 units (100 mcg)

Ipamorelin6 units (100 mcg)

Combined Total200 mcg total

Weeks 3–4

CJC-12959 units (150 mcg)

Ipamorelin9 units (150 mcg)

Combined Total300 mcg total

Weeks 5–8

CJC-129512 units (200 mcg)

Ipamorelin12 units (200 mcg)

Combined Total400 mcg total

Weeks 9–12

CJC-129515 units (250 mcg)

Ipamorelin15 units (250 mcg)

Combined Total500 mcg total

How to Inject

Draw both peptides into the same syringe

Inject once daily before bed

Advanced Protocol (Morning + Night)

Weeks 1–2

MorningCJC-1295: 50 mcg + Ipamorelin: 50 mcg

NightCJC-1295: 100 mcg + Ipamorelin: 100 mcg

Daily Total150 mcg each

Weeks 3–4

MorningCJC-1295: 100 mcg + Ipamorelin: 100 mcg

NightCJC-1295: 100 mcg + Ipamorelin: 100 mcg

Daily Total200 mcg each

Weeks 5–8

MorningCJC-1295: 100 mcg + Ipamorelin: 100 mcg

NightCJC-1295: 150 mcg + Ipamorelin: 150 mcg

Daily Total250 mcg each

Weeks 9–12

MorningCJC-1295: 150 mcg + Ipamorelin: 150 mcg

NightCJC-1295: 150 mcg + Ipamorelin: 150 mcg

Daily Total300 mcg each

Morning: Fasted (or at least 2–3 hours after eating)
Night: 30–60 minutes before bed (fasted)
Why split dosing: Mimics natural GH pulsatility and may enhance total daily GH output

When & Where to Inject

• Subcutaneous injection
• Abdomen, thigh, or upper arm
• Best used fasted before sleep
• Rotate injection sites consistently

Reconstitution & Dosing (Blended Vial)

Vial 5 mg CJC-1295 + 5 mg Ipamorelin

Water 3.0 mL

Concentration 1.67 mg/mL (each peptide)

Conversion 1 unit = 16.7 mcg CJC + 16.7 mcg Ipamorelin

Reconstitution Steps

Draw 3.0 mL bacteriostatic water

Inject slowly down the vial wall

Gently swirl (do not shake)

Allow powder to fully dissolve

Storage

Store lyophilized vial refrigerated or frozen

After mixing: keep refrigerated (2–8°C)

Protect from light and avoid shaking

Use Window

Use within ~4 weeks after reconstitution

Monitoring During Use

• Sleep quality and deep sleep response
• Recovery and soreness
• Body composition changes
• IGF-1 levels on longer cycles

Benefits

• Synergistic GH release
• Improved recovery and tissue repair
• Enhanced fat metabolism
• Lean muscle support
• Better sleep quality

Potential Side Effects

• Mild injection site irritation
• Headache (rare)
• Water retention
• Temporary hunger increase

Stacking Strategies

• Recovery: Add BPC-157
• Advanced: Add IGF-1 LR3
• Body Composition: Pair with disciplined sleep, training, and nutrition

Important Notes

• This is one of the most commonly used GH peptide combinations
• Blended and separate setups can produce the same dose outcome
• 100 mcg each = 200 mcg combined total
• Consistency matters more than aggressive dosing

Important Disclaimer

CJC-1295 (NO DAC) and Ipamorelin are not FDA-approved and are intended for research purposes only.

Peptide Directory →